Search form

Search form

U.S. scientists are looking into the potential of nanoparticles to deliver drugs directly to tumors and to detect the spread and recurrence of cancer. The federal government has allotted about $145 million for the research, as experts explore ways to overcome medical and engineering challenges.

Related Summaries

Contract research organizations have helped the life-sciences sector test medical products for two decades, but opponents fear insufficient government oversight could compromise drug and patient safety. An FDA official said the agency is "looking at modernizing its regulations" to ensure that all parties involved in human trials will be held fully accountable.

A discussion at the recent European Association of Urology meeting concluded that PET/CT and PET are not currently the preferred method of staging prostate cancer LN. However one presenter discussed using radioactive tracers and how they impact diagnoses, said a news release from UroToday.com.

Data released by IDC-HII show that participation in health information exchanges is increasing. A poll of CIOs at community hospitals found 22.7% say they are participating in an HIE, 18.2% expect to join one in less than a year and 27.3% are looking into HIE participation.

Researchers used magnetic resonance spectroscopy to study urine and concluded that it may be used in a new method of finding links between health and diet. The study confirms that metabolic profiling can help physicians understand how diet can contribute to an increased risk of certain diseases, one of the scientists said.

U.S. scientists are looking into the potential of nanoparticles to deliver drugs directly to tumors and to detect the spread and recurrence of cancer. The federal government has allotted about $145 million for the research, as experts explore ways to overcome medical and engineering challenges.